Onco Therapies Ltd. - (Amalgamated) - Stock Valuation and Financial Performance

BSE: 0 | NSE: | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Onco Therapies

M-Cap below 100cr DeciZen not available

Onco Therapies Ltd. - (Amalgamated) stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
0 Cr.
52-wk low:
0
52-wk high:
0

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray of Onco Therapies:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Value Creation Index Colour Code Guide

Dec'11Dec'12TTM
ROCE % -0.3%9.3%-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 79.8162162
Sales YoY Gr.-103.3%-
Adj EPS -11890
YoY Gr.-NA-
BVPS (₹) 525.8617.20
Adj Net
Profit
-2.721.40
Cash Flow from Ops. -56.7-45-
Debt/CF from Ops. -4.4-3.7-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANA103.3%
Adj EPS NANANANA
BVPSNANANA17.4%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Dec'11Dec'12TTM
Return on
Equity %
-2.115.60
Op. Profit
Mgn %
8.625.6NAN
Net Profit
Mgn %
-3.313.20
Debt to
Equity
21.1-
Working Cap
Days
07740
Cash Conv.
Cycle
0-20

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials - Onco Therapies Ltd. - (Amalgamated)

Standalone Consolidated
TTM EPS (₹) 0 -
TTM Sales (₹ Cr.) 162 -
BVPS (₹.) 0 -
Reserves (₹ Cr.) 146 -
P/BV 0.00 -
PE 0.00 -
From the Market
52 Week Low / High (₹) - / -
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 0
Equity (₹ Cr.) 0
Face Value (₹) 10
Industry PE 44.3

Management X-Ray of Onco Therapies:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Onco Therapies

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSDec'11Dec'12
Sales79.77162.13
Operating Expenses 72.91120.76
Manufacturing Costs8.1511.46
Material Costs30.4684.97
Employee Cost 6.118.82
Other Costs 28.1915.51
Operating Profit 6.8641.37
Operating Profit Margin (%) 8.6%25.5%
Other Income 0.051.05
Interest 1.385.20
Depreciation 8.1710.52
Exceptional Items 00
Profit Before Tax -2.6426.70
Tax 04.70
Profit After Tax -2.6422
PAT Margin (%) -3.3%13.6%
Adjusted EPS (₹)-11.091.4
Dividend Payout Ratio (%)0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSDec'11Dec'12

Equity and Liabilities

Shareholders Fund 126.51148.50
Share Capital 2.412.41
Reserves 124.10146.10
Minority Interest00
Debt164.7683.77
Long Term Debt164.7664.87
Short Term Debt018.90
Trade Payables35.1828.84
Others Liabilities 124.65245.72
Total Liabilities 451.11506.84

Fixed Assets

Gross Block148.61152.19
Accumulated Depreciation18.1428.63
Net Fixed Assets130.47123.56
CWIP 0.764.84
Investments 00
Inventories20.7433.52
Trade Receivables13.3020.64
Cash Equivalents 1.283.13
Others Assets284.55321.14
Total Assets 451.11506.84

Cash Flow

(All Figures are in Crores.)
PARTICULARSDec'11Dec'12
Cash Flow From Operating Activity -56.67-44.95
PBT -2.6426.70
Adjustment 10.9810.97
Changes in Working Capital -60.45-82.7
Tax Paid -4.58-4.60
Cash Flow From Investing Activity -12.53-6.07
Capex -12.56-6.18
Net Investments 00
Others 0.040.11
Cash Flow From Financing Activity 29.6051.40
Net Proceeds from Shares 9.790
Net Proceeds from Borrowing 00
Interest Paid -0.02-2.29
Dividend Paid 00
Others 19.8453.68
Net Cash Flow -39.600.38
PARTICULARSDec'11Dec'12
Ratios
ROE (%)-2.0916
ROCE (%)-0.349.28
Asset Turnover Ratio0.180.34
PAT to CFO Conversion(x)N/A-2.04
Working Capital Days
Receivable Days6038
Inventory Days9461
Payable Days422138

Onco Therapies Ltd. - (Amalgamated) Stock News

Onco Therapies Ltd. - (Amalgamated) FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Onco Therapies on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Onco Therapies stood at ₹0.00.
The latest P/E ratio of Onco Therapies as of 01-Jan-1970 05:30 is 0.00.
The latest P/B ratio of Onco Therapies as of 01-Jan-1970 05:30 is 0.00.
The 52-week high of Onco Therapies is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Onco Therapies is ₹162.1 ( Cr.) .

About Onco Therapies Ltd. - (Amalgamated)

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.